Objective: The purpose of this study was to investigate whether pre-treatment subject characteristics and weight change during the first weeks of a low-calorie diet (LCD) can predict weight loss outcomes at the end of a controlled 8-week weight loss period in overweight and obese adults. Subjects: A total of 932 overweight and obese subjects of both genders were included at eight European centers, and underwent an 8-week LCD period. Results: The weight loss at week 8 was positively correlated with initial body weight (Spearman's r ¼ 0.62), height (r ¼ 0.43), body mass index (r ¼ 0.43), waist (r ¼ 0.48) and hip circumference (r ¼ 0.33), sagittal diameter (r ¼ 0.45), fat mass (r ¼ 0.35) and fat-free mass (r ¼ 0.52), and gender (r ¼ À0.36) (all Po0.01). In the multivariate regression model, adjusted for center, only initial body weight, early weight loss (week 1) and weight loss at week 3 were significant predictors of weight loss outcome at week 8: weight loss (kg) at week 8 ¼ 0.09 þ 0.046 Â baseline body weight (kg)À0.311 Â weight loss (kg) at week 1 þ 1.284 Â weight loss (kg) at week 3 (R 2 ¼ 68%, Po0.0001). A weight loss of X2.6 kg at week 1 during the LCD period was identified as the optimal cut-off predictor for at least 10 kg weight loss at week 8. Conclusions: This study suggests that initial body weight, early weight loss (week 1) and weight loss at week 3 are predictors of final weight loss during an 8-week LCD, and may be used as early biomarkers of subsequent responses to an LCD diet.
Introduction
It has been predicted that in the future optimal management of obesity will be based on individualized treatment determined by markers for responders and non-responders to diet, exercise and behavior modification. Substantial efforts have been made to identify predictors of weight loss in obese individuals undergoing treatment (Webster and Garrow, 1989; Astrup et al., 1995; Hansen et al., 2001; Hainer et al., 2005; Mutch et al., 2007; Fabricatore et al., 2009) . However, there are no specified cut-off criteria for predicting weight loss by proper estimation of pre-treatment characteristics that are documented by the literature. Obese subjects differ in the rate at which they lose weight during slimming programs. Heavier patients normally lose weight more rapidly than their leaner counterparts, which may be a function of a greater energy deficit in the heavier patients when on diets with a fixed energy prescription (Webster and Garrow, 1989; Hansen et al., 2001) . Some studies have suggested that larger weight losses in the first few weeks of treatment are associated with better long-term weight loss results (Dubbert and Wilson, 1984; Wadden and Stunkard, 1986) . Psychological, behavioral and biological predictors have a weak predictive power (Dubbert and Wilson, 1984; Webster and Garrow, 1989; Rössner, 1992) . Several studies suggest various predictors of weight loss during dietary regimen (Wadden et al., 1992; Astrup et al., 1995) . The results of a randomized, multicenter study have suggested that initial body weight and age have a substantial function in prediction of total weight loss, but with a low power of prediction (Hansen et al., 2001) . Another study demonstrated that plasma dihydrotestosterone, 24-h energy expenditure, fat oxidation and plasma noradrenaline, may be prognostic markers for weight loss outcome in obese women (Astrup et al., 1995) . The clinical value of these results is limited due to low power of prediction. It is important that any predictor should be easy to determine, and that it should be feasible to implement it in general medical practice if it is to be useful in planning the individualized treatment of obese patients. The aim of this study was to determine whether pre-treatment characteristics and early weight change during the first weeks of a low-calorie diet (LCD) could predict weight loss outcome at the end of a carefully controlled 8-week, B800 to 1000 kcal/day, weight loss period in a large cohort of overweight and obese adults across Europe.
Materials and methods

Experimental design
The Diogenes project (http://www.diogenes-eu.org) is a Pan-European, randomized, controlled dietary intervention study investigating the effects of dietary protein and glycemic index on weight (re)gain, and metabolic and cardiovascular risk factors in obese and overweight families in eight European centers .
Families were recruited by using a number of strategies, including a waiting list for weight loss projects, referrals from local general practices or from other medical departments, posting of flyers and posters in public places, and advertising through radio, television, newspapers and the internet. Informed consent was obtained according to the Declaration of Helsinki II. The study was approved by the local ethical committees in the respective countries.
A total of 891 families with at least one overweight/ obese parent (body mass index, BMIX27 kg/m 2 ) underwent screening. Details of the methodology of the project are given in papers by Larsen et al. (2009) and Moore et al. (2009) .
Dietary intervention
Parents (n ¼ 932 subjects) who were eligible for inclusion (27p BMI p42 kg/m 2 ) (details of inclusion and exclusion criteria in the study by Moore et al. (2009) ) started an 8-week LCD with four sachets of powder drink, soup and crème (Modifast, Nutrition et Santé, France) , providing the subjects with 800-880 kcal/day, with the addition of about 200 g of raw vegetables. The Modifast products consisted of 54 g of proteins a day, B5 g a day of essential fatty acids, and the daily requirement for vitamins and minerals. A study dietician held six dietary sessions with the enrolled subjects during the 8-week LCD period. Over the 8-week LCD period, subjects' daily food intake consisted of four Modifast powders eaten at intervals distributed throughout the day to replace breakfast, lunch, dinner and one snack. In addition to the four Modifast powders and 200 g/day of raw vegetables, patients were permitted to drink water, coffee/tea, calorie-free soft drinks and chew/eat sugar-free gums/pastilles without any limitations.
Anthropometry
All patients underwent a full medical examination before and after the 8-week weight loss period. Waist circumference, hip circumference and sagittal diameter were measured according to the protocols (Table 1) . At the medical examinations, body composition was assessed by dual energy X-ray absorptiometry (Lunar Radiation, Madison, WI, USA) or bioelectrical impedance analysis (QuadScan 4000; Bodystat, Douglas, Isle of Man, British Isles). Body weight was measured at weeks 0, 2, 3, 4, 5, 6 and at the end of the LCD period in week 8 (Table 1) .
Statistics
Statistical analyses were performed with the Statistical Package for the Social Sciences (SPSS, version 13.0; SPSS, Chicago, IL, USA). Results are presented as mean ± s.e.m. Statistical significance was assigned at Po0.05. Correlation analyses were carried out to examine the relationship between baseline characteristics, weight loss at week 1 and week 3, and weight loss at week 8 using Spearman's 
Abbreviations: CID1, clinical investigation day 1; LCD, low-calorie diet. a Measurements made before and after the 8-week LCD period.
correlation coefficient. Subsequently, a multiple regression analysis adjusted for center was performed to identify the effects of single and/or independent predictors of weight loss during the LCD period. With the intention to identify the effect of initial weight loss on 8-week outcome, we used sensitivity and specificity analyses with a target of 10 kg final weight loss. Early weight loss cut-points were set at X2, X2.6, X3 and X4 kg, and the sensitivity, specificity and accuracy of each of these for predicting at least 10 kg weight reduction at week 8 was calculated. In this analysis, the sensitivity showed the relative proportion of responders (at least 10 kg weight loss) who achieved the early weight loss, whereas specificity was the relative proportion of nonresponders who did not achieve the early weight loss. In addition, we calculated the predictive value of each of the target cut-off points. Receiver-operator characteristic table was constructed with sensitivity against 1 À specificity for each of the early weight loss targets (week 1) ( Table 4) .
Results
Anthropometric measurements and body composition are shown in Table 2 . Nine-hundred-and-thirty-two patients initiated the LCD treatment, and 801 subjects (86%) completed the 8-week LCD period. The dropout rate was 14%. The mean weight loss at the end of the LCD period was 10.8 ± 0.13 kg compared with the mean weight loss in week 1 (2.8 ± 0.05 kg) and week 3 (5.4 ± 0.07 kg), respectively (Table 2) . Men showed greater weight loss during the LCD period than women, both when expressed in kilograms (men: 12.67 ± 0.24 kg, women: 9.87 ± 0.13 kg, P ¼ 0.0001) and as a percentage of their initial body weight (men: 11.6 ± 0.22%, women: 10.4 ± 0.11%, P ¼ 0.0001) ( Table 2) .
Weight loss at the end of the LCD period (week 8) was positively correlated with baseline values of body weight (Spearman's r ¼ 0.62, Po0.01), height (Spearman's r ¼ 0.43, Po0.01), BMI (Spearman's r ¼ 0.43, Po0.01) and sagittal diameter (Spearman's r ¼ 0.45, Po0.01; Table 3 ). The simple correlations between weight change at the first and third week during the LCD and the studied parameters are shown in Table 3 . Initial body weight, height and sagittal diameter had a significant positive relation with weight loss at week 1 and week 3.
Multiple regression analyses showed that only initial body weight (R 2 ¼ 0.21, P ¼ 0.0001) and gender (R 2 ¼ 0.03, P ¼ 0.0001) were independent predictors of weight loss during the LCD period when adjusted for center. Together, these determinants explained 42% of the total variation (R 2 ¼ 0.420, P ¼ 0.0001). Baseline height, BMI, age, waist and Gender showed no further impact on the final weight loss. The total R 2 coefficient and P-value were R 2 ¼ 0.684, P ¼ 0.0001, that is, together these determinants explained 68% of variation in the final weight loss achieved at week 8. A cross-validation analysis was performed by splitting the cohort into two groups by random. It showed consistent with the results for both cohorts.
The characteristics related to the selected early weight loss cut-off points are described in Table 4 . The ideal early weight loss should combine both sensitivity and specificity values above 70%. A weight loss of at least 2.6 kg at week 1 appeared to produce values close to the criteria described above (Table 4) . For subjects achieving a weight loss of at least 2.6 kg at week 1 during the LCD period, the positive predictive power of achieving at least 10 kg weight loss at the end of the diet was 69.3% and the negative predictive power À68.5%.
Discussion
It is a challenge to prescribe the best weight loss treatment at an individual level, and to find early predictors of success or failure. Over the past 30 years a large body of evidence has been generated on the predictors of weight loss, but only a very small proportion of the variance in weight loss has been explained by the identified predictors. However, many of the studies have included quite a small number of subjects, and their statistical power to identify predictors of ultimate weight loss has therefore been limited. Standardized biomarkers that can easily predict weight loss outcome for short-or long-term periods, with objective predictors and narrow confidence intervals, are not easily obtainable. Therefore, this study analyzed anthropometric predictors of weight loss with an aim to expanding the understanding of the impact of pre-treatment factors on body weight control, as well as the role of early weight loss during an LCD period, in a large cohort of patients from eight different European centers. One of the major strengths of this study was its sample size. Only one paper reports a study with more participants (n ¼ 975) (Dhurandhar et al., 1999) . Other studies have been performed in smaller cohorts with less statistical power (Webster and Garrow, 1989; Wadden et al., 1992; Astrup et al., 1995; Hansen et al., 2001; Hainer et al., 2005; Fabricatore et al., 2009) . In addition, this study assessed predictors of weight loss separately in women and men, and confirms that men lose weight more rapidly in the initial stage of a slimming program than women (12.67 ± 0.22 vs 9.86 ± 0.13, P ¼ 0.0001). This has been shown previously (Sartorio et al., 2005; Anderson et al., 2007) . The reason is most likely the gender difference in body composition, and the consequent differences in total energy expenditure, appetite control and reproductive hormone signals, resulting in gender-specific responsiveness to weight loss programs (Dye and Blundell, 1997; Sartorio et al., 2005; Anderson et al., 2007) .
This study has revealed some of the key factors involved and their function in the prediction of weight loss during an 8-week LCD. Initial body weight is a strong predictor for further weight reduction. The body of evidence suggests that heavier patients typically lose weight more rapidly than lighter patients (Wadden and Stunkard, 1986; Wadden et al., 1992; Dhurandhar et al., 1999; Hansen et al., 2001 ). Under the same absolute level of energy intake (800 kcal/day), it is obvious that subjects with higher body mass and thus higher energy expenditure will have a greater energy gap and will lose weight faster. This study demonstrates that initial body weight was positively correlated with an early weight loss as well as with the final weight reduction during the LCD period. More interestingly, the initial weight loss was a strong predictor of final weight loss (week 8), and subsequently could be related to longer-term outcomes. This finding is consistent with previous studies (Wadden et al., 1992; Dhurandhar et al., 1999; Hansen et al., 2001; Finer et al., 2006; Hollis et al., 2008; Fabricatore et al., 2009) showing the importance of assessment of initial body weight .01) were the most relevant correlates of weight loss both at the end of the treatment and at 1-year follow-up (Wadden et al., 1992) . In addition, Leibbrand and Fichter (2002) have reported that initial BMI was the only significant predictor of weight outcome at 18-month followup (R 2 ¼ 0.07, Po0.01). In other studies no significant correlations between initial body weight and weight loss are described (Westerterp-Plantenga et al., 1998; Teixeira et al., 2004) . Baseline body weight, treatment group and age explained only 8% of the variation in 24 months weight change induced by a food-based hypocaloric diet in the STORM trial (Hansen et al., 2001 ). In the Diogenes study, the regression model showed that the R 2 regression coefficient increased significantly (from 0.420 to 0.509, P ¼ 0.0001) when the early weight loss (week 1) was added to the model. This suggests that early weight loss (week 1) during the LCD period is a strong predictor of final weight reduction (week 8). This finding is confirmed and emphasized by other studies demonstrating that patients' early weight loss is a strong predictor of short-and long-term weight loss success (Wadden et al., 1992; Finer et al., 2006; Fabricatore et al., 2009) . The inclusion of the factor 'initial weight loss' to the regression model increases substantially the proportion of variation in total 8-week weight loss. One should note that this increase in predicting power is only partly due to the fact that initial weight loss predicts final weight loss, as the initial weight loss is a dependent part of the final weight loss. Nevertheless, in the clinical setting it is a valuable tool for predicting the final 8-week weight loss with certainty after only 1 week of LCD. Taken together, these data show the importance of the proper assessment of initial body weight, weight loss at the first week of the diet, and of gender. Moreover, weight loss at week 3 demonstrated strong predictive power and could explain a relevant proportion of the variance in the total weight loss (R 2 ¼ 0.19, P ¼ 0.0001). Individual subjects might lose weight at a slower rate than other subjects in the early stages of LCD, but could 'catch-up' and ultimately achieve a better weight loss than others at the end of the diet. It could be speculated that this data suggest that reducing energy intake should start as early as possible in weight loss programs. This finding could also be partly explained by the high attendance and low dropout rate (14%) during the LCD period. In our model of prediction, three variables exhibited significant predictive power: initial body weight, weight loss at week 1 and weight loss at week 3 of the LCD period. Taken together, these three determinants predicted 68% variance in the final weight loss. To our knowledge, none of the other reported prognostic markers have predicted such a large proportion of the variance of weight loss outcomes. The significance of body weight assessment during weight loss programs, and the proper evaluation of early weight loss and at week 3 weight loss cannot be overemphasized.
Our study demonstrates that an early weight loss (week 1) of X2.6 kg could predict a weight loss outcome of at least 10 kg during the 8-week LCD period. We showed that a cutoff point of at least 2.6 kg had relatively high sensitivity (B70%) and specificity (B68%). Moreover, an early weight loss target of X2.6 kg had a good predictive value (69.3%). This cut-off point also had a good negative predictive value (68.5%). This study suggests that a cut-off weight loss target of X2.6 kg in the first week of a weight loss program could be used as a predictor of later success on an 8-week LCD.
Conclusion
The main objective of the study was to identify anthropometric factors that could predict weight loss outcome of an 8-week LCD period with a fixed energy intake. The results demonstrate the importance of initial body weight as baseline characteristic of the obese patient, as well as its strong predictive power in relation to weight reduction outcome at the end of the LCD period. Second, gender has a significant impact on the propensity to lose weight and maintain body weight. Third, early weight loss and weight loss at week 3 during LCD had very strong predictive potential for the final weight loss (week 8). Evaluating the early weight loss during the LCD is an essential part of the evolvement of individualized treatment of obesity. Furthermore, this analysis demonstrated a cut-off target for early weight loss during the LCD period, which should be considered when starting a diet. Taken together, all these factors could improve the development of adequate prognostic models of weight loss. This predictive model of weight loss could be easily implemented and used in daily medical practice.
